Vor Biopharma Inc’s filing revealed that its CHIEF MEDICAL OFFICER Attar Eyal C. unloaded Company’s shares for reported $12918.0 on Dec 27 ’24. In the deal valued at $1.25 per share,10,334 shares were sold. As a result of this transaction, Attar Eyal C. now holds 81,439 shares worth roughly $0.11 million.
Then, EYAL ATTAR bought 10,334 shares, generating $8,660 in total proceeds.
Before that, Attar Eyal C. sold 14,645 shares. Vor Biopharma Inc shares valued at $20,357 were divested by the CHIEF MEDICAL OFFICER at a price of $1.39 per share. As a result of the transaction, Attar Eyal C. now holds 96,063 shares, worth roughly $0.13 million.
Wedbush initiated its Vor Biopharma Inc [VOR] rating to an Outperform in a research note published on July 26, 2022; the price target was $18. A number of analysts have revised their coverage, including Goldman’s analysts, who began to cover the stock in late April with a ‘”a Neutral”‘ rating. H.C. Wainwright began covering VOR with “Buy” recommendation on December 17, 2021. Robert W. Baird started covering the stock on December 03, 2021. It rated VOR as “an Outperform”.
Price Performance Review of VOR
On Tuesday, Vor Biopharma Inc [NASDAQ:VOR] saw its stock fall -2.19% to $1.34. Over the last five days, the stock has lost -22.99%. Vor Biopharma Inc shares have risen nearly 20.72% since the year began. Nevertheless, the stocks have fallen -52.98% over the past one year. While a 52-week high of $2.59 was reached on 01/06/25, a 52-week low of $0.63 was recorded on 01/02/25. SMA at 50 days reached $0.9921, while 200 days put it at $1.1367.
Levels Of Support And Resistance For VOR Stock
The 24-hour chart illustrates a support level at 1.2733, which if violated will result in even more drops to 1.2067. On the upside, there is a resistance level at 1.4433. A further resistance level may holdings at 1.5467. The Relative Strength Index (RSI) on the 14-day chart is 56.75, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.1441, which suggests price will go down in the next trading period. Percent R suggests that price movement has been low at 46.90%. Stochastics %K at 61.43% indicates the stock is a holding.
How much short interest is there in Vor Biopharma Inc?
A steep rise in short interest was recorded in Vor Biopharma Inc stocks on 2024-10-15, dropping by -0.83 million shares to a total of 1.71 million shares. Yahoo Finance data shows the prior-month short interest on 2024-09-13 was 2.54 million shares. There was a decline of -48.84%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on December 02, 2021 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $30 price target.
